As previously reported, BofA downgraded UiPath (PATH) to Underperform from Neutral with a price target of $10, down from $18, following the company’s “disappointing” FY26 outlook. Macro pressure in the Federal vertical was cited, though commentary suggests that pressure is more broad-based and “unlikely to abate soon,” says the analyst, who sees few catalysts for the shares, even at current level.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- UiPath price target lowered to $11 from $13 at Wells Fargo
- UiPath’s Financial Outlook Impacted by Delayed Deals and Conservative Growth Forecast Amidst Economic Challenges
- UiPath downgraded to Underperform from Neutral at BofA
- UiPath’s Mixed Q4 Results and AI Demand Justify Hold Rating Amid Macroeconomic Challenges
- UiPath price target lowered to $12 from $15 at Barclays